Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The Indiana Myeloma Registry

Indiana University1 site in 1 country2,500 target enrollmentJune 18, 2018

ConditionsPlasma Cell Dyscrasias

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Plasma Cell Dyscrasias
Sponsor: Indiana University
Enrollment: 2500
Locations: 1
Primary Endpoint: Create a repository
Status: Recruiting
Last Updated: 5 months ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Registry

clinicaltrials.gov

Start Date

June 18, 2018

End Date

June 30, 2028

Last Updated

5 months ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Indiana University

Responsible Party

Principal Investigator

Attaya Suvannasankha

Clinical Professor of Clinical Medicine

Indiana University

Eligibility Criteria

Inclusion Criteria

•Male or female patients ≥ 18 years of age at the time of informed consent
•Has been diagnosed with or is suspected to have one of the following:
•Monoclonal Gammopathy of Undetermined Significance (MGUS)
•Smoldering Multiple Myeloma
•Multiple Myeloma
•Bony or Soft Tissue Plasmacytoma
•Primary Amyloidosis

Exclusion Criteria

•\< 18 years of age
•Have not been diagnosed with one of the following:
•Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Outcomes

Primary Outcomes

Create a repository

Time Frame: 5 years

The primary objective of this study is to provide a mechanism to store comprehensive clinical, genomic, demographic, social, environmental and quality of life data from subjects with plasma cell dyscrasias